Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis (2015)
- Authors:
- USP affiliated authors: RIOS, WENDY MARTIN - FMRP ; BRANDAO, IZAIRA TINCANI - FMRP ; MASSON, ANA PAULA - FMRP ; RAMOS, SIMONE GUSMÃO - FMRP ; SILVA, CELIO LOPES - FMRP
- Unidade: FMRP
- DOI: 10.1093/jac/dkv023
- Subjects: QUIMIOTERAPIA; IMUNOTERAPIA; TRANSCRIÇÃO GÊNICA; TUBERCULOSE
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Antimicrobial Chemotherapy
- ISSN: 0305-7453
- Volume/Número/Paginação/Ano: v. 70, n. 6, p. 1774-1783, 2015
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
RODRIGUES, Rodrigo F et al. Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis. Journal of Antimicrobial Chemotherapy, v. 70, n. 6, p. 1774-1783, 2015Tradução . . Disponível em: https://doi.org/10.1093/jac/dkv023. Acesso em: 19 nov. 2024. -
APA
Rodrigues, R. F., Zárate-Bladés, C. R., Rios, W. M., Soares, L. S., Souza, P. R. M., Brandão, I. T., et al. (2015). Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis. Journal of Antimicrobial Chemotherapy, 70( 6), 1774-1783. doi:10.1093/jac/dkv023 -
NLM
Rodrigues RF, Zárate-Bladés CR, Rios WM, Soares LS, Souza PRM, Brandão IT, Masson AP, Arnoldi FGC, Ramos SG, Letourneur F, Jacques S, Cagnard N, Chiocchia G, Silva CL. Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis [Internet]. Journal of Antimicrobial Chemotherapy. 2015 ; 70( 6): 1774-1783.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/jac/dkv023 -
Vancouver
Rodrigues RF, Zárate-Bladés CR, Rios WM, Soares LS, Souza PRM, Brandão IT, Masson AP, Arnoldi FGC, Ramos SG, Letourneur F, Jacques S, Cagnard N, Chiocchia G, Silva CL. Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis [Internet]. Journal of Antimicrobial Chemotherapy. 2015 ; 70( 6): 1774-1783.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/jac/dkv023 - Immunotherapy of tuberculosis with Mycobacterium leprae HSP65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity
- Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis
- Immunization with plasmids encoding M2 acetylcholine muscarinic receptor epitopes impairs cardiac function in mice and induces autophagy in the myocardium
- pVAXhsp65 vaccination primes for high IL-10 production and decreases experimental encephalomyelitis severity
- P2×7 purinergic signaling in dilated cardiomyopathy induced by auto-immunity against muscarinic M2 receptors: autoantibody levels, heart functionality and cytokine expression
- Avaliação de resposta autoimune durante a imunoterapia com DNAhsp65 da tuberculose
- Vacinas de DNA codificando antígenos de glioblastoma e proteínas imunomoduladoras: construção e avaliação da imunogenicidade
- Estudo catalíticos de oxigenação de hidrocarbonetos utilizando metaloporfirinas fluorossubstituídas como catalisadores em meio homogêneo e heterogêneo
- Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB4 reduction but not PGE2 increment
- Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis
Informações sobre o DOI: 10.1093/jac/dkv023 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
